Elevations in Total Serum Bile Acids During Bulevirtide Treatment Are Asymptomatic and Not Associated With Adverse Events of Interest in Patients With Chronic Hepatitis Delta

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


Elevations in Total Serum Bile Acids During Bulevirtide Treatment Are Asymptomatic and Not Associated With Adverse Events of Interest in Patients With Chronic Hepatitis Delta

	AASLD 2025 Nov 7-11 Wash DC Pietro Lampertico1,2